.png)
Leading a compassionate new era of medicine, we have dedicated our lives to giving patients back theirs. Many patients with significant disease spend much of their time at infusion centers with an IV in their arm. Touched by their burden, we strive to make the delivery of vital treatments gentler and more convenient.
Providing the freedom of self-injectable care to patients who rely on intravenous (“IV”) biologics
Millions of patients with significant disease spend day after day at an infusion center, with an IV in their arm. It’s painful, time-consuming and costly for everyone involved. Living with disease doesn’t have to be this challenging. We’ve set out to maximize the true potential of life-changing biologics by empowering patients to administer their own medicine via a single, simple injection, wherever they feel most comfortable.
We apply a deep knowledge of formulation science and technology to transform the delivery of essential biologics from IV to SQ forms. Our approach allows patients to administer their own medicine via a single, simple injection, wherever they feel most comfortable. By helping patients avoid frequent, sometimes painful visits to an infusion center, we hope to realize the true potential of life-changing therapies.
Gentle delivery of vital biologics
We are developing an internal portfolio of proprietary subcutaneous (“SQ”) therapeutics that incorporate our innovative formulation platform, SQore™. We are also collaborating with pharmaceutical and biotechnology companies, leveraging the SQore™ platform to enhance the delivery and characteristics of their biologic medicines.
Visit us at www.ComeraLifeSciences.com